# Cetirizine hydrochloride and Pseudoephedrine hydrochloride

NDC: 45802-147
Generic name: Cetirizine hydrochloride, Pseudoephedrine hydrochloride
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20200331

FDA application: ANDA210719

## Active ingredients

- CETIRIZINE HYDROCHLORIDE: 5 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE: 120 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-147"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-147
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3260111b-35da-4f95-8081-51eae4b1ef45